Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Cardiovascular, Cognitive and Subjective Effects of Atomoxetine in Combination With Intravenous Methamphetamine

NCT02014064 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT02014064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02014064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Cardiovascular, Cognitive and Subjective Effects of Atomoxetine in Combination With Intravenous Methamphetamine
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2009
Completion date
August 31, 2012
Enrollment
41 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

continuous methamphetamine dependence, methamphetamine dependence in remission